FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034773963> ?p ?o ?g. }

• W2034773963 endingPage "45" @default.
• W2034773963 startingPage "40" @default.
• W2034773963 abstract "BACKGROUND The potential cardiotoxicy of the doxorubicin-paclitaxel regimen, when paclitaxel is given shortly after the end of the anthracycline infusion, is an issue of concern, as suggested by small single institution Phase II studies. METHODS In a large multicenter Phase III trial, 275 anthracycline naive metastatic breast carcinoma patients were randomized to receive either doxorubicin (60 mg/m2) followed 30 minutes later by paclitaxel (175 mg/m2 3-hour infusion; AT) or a standard doxorubicin-cyclophosphamide regimen (AC; 60/600 mg/m2). Both treatments were given once every 3 weeks for a maximum of six cycles. Close cardiac monitoring was implemented in the study design. RESULTS Congestive heart failure (CHF) occurred in three patients in the AT arm and in one patient in the AC arm (P = 0.62). Decreases in left ventricular ejection fraction to below the limit of normal were documented in 33% AT and 19% AC patients and were not predictive of CHF development. CONCLUSIONS AT is devoid of excessive cardiac risk among metastatic breast carcinoma patients, when the maximum planned cumulative dose of doxorubicin does not exceed 360 mg/m2. Cancer 2003;97:40–5. © 2003 American Cancer Society. DOI 10.1002/cncr.10914" @default.
• W2034773963 created "2016-06-24" @default.
• W2034773963 creator A5012143202 @default.
• W2034773963 creator A5012884004 @default.
• W2034773963 creator A5014711481 @default.
• W2034773963 creator A5032461564 @default.
• W2034773963 creator A5048669566 @default.
• W2034773963 creator A5050421775 @default.
• W2034773963 creator A5051980635 @default.
• W2034773963 creator A5059795069 @default.
• W2034773963 creator A5060272511 @default.
• W2034773963 creator A5061483613 @default.
• W2034773963 creator A5074079751 @default.
• W2034773963 creator A5087380706 @default.
• W2034773963 date "2002-12-18" @default.
• W2034773963 modified "2023-09-30" @default.
• W2034773963 title "Doxorubicin-paclitaxel" @default.
• W2034773963 cites W1828224642 @default.
• W2034773963 cites W1833330468 @default.
• W2034773963 cites W1837236202 @default.
• W2034773963 cites W1924401190 @default.
• W2034773963 cites W1960713055 @default.
• W2034773963 cites W1977105311 @default.
• W2034773963 cites W2049129583 @default.
• W2034773963 cites W2108028042 @default.
• W2034773963 cites W2133003338 @default.
• W2034773963 cites W2318605753 @default.
• W2034773963 cites W2541820485 @default.
• W2034773963 cites W4293241248 @default.
• W2034773963 doi "https://doi.org/10.1002/cncr.10914" @default.
• W2034773963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12491503" @default.
• W2034773963 hasPublicationYear "2002" @default.
• W2034773963 type Work @default.
• W2034773963 sameAs 2034773963 @default.
• W2034773963 citedByCount "38" @default.
• W2034773963 countsByYear W20347739632012 @default.
• W2034773963 countsByYear W20347739632014 @default.
• W2034773963 countsByYear W20347739632015 @default.
• W2034773963 countsByYear W20347739632016 @default.
• W2034773963 countsByYear W20347739632017 @default.
• W2034773963 countsByYear W20347739632020 @default.
• W2034773963 countsByYear W20347739632021 @default.
• W2034773963 countsByYear W20347739632022 @default.
• W2034773963 countsByYear W20347739632023 @default.
• W2034773963 crossrefType "journal-article" @default.
• W2034773963 hasAuthorship W2034773963A5012143202 @default.
• W2034773963 hasAuthorship W2034773963A5012884004 @default.
• W2034773963 hasAuthorship W2034773963A5014711481 @default.
• W2034773963 hasAuthorship W2034773963A5032461564 @default.
• W2034773963 hasAuthorship W2034773963A5048669566 @default.
• W2034773963 hasAuthorship W2034773963A5050421775 @default.
• W2034773963 hasAuthorship W2034773963A5051980635 @default.
• W2034773963 hasAuthorship W2034773963A5059795069 @default.
• W2034773963 hasAuthorship W2034773963A5060272511 @default.
• W2034773963 hasAuthorship W2034773963A5061483613 @default.
• W2034773963 hasAuthorship W2034773963A5074079751 @default.
• W2034773963 hasAuthorship W2034773963A5087380706 @default.
• W2034773963 hasBestOaLocation W20347739631 @default.
• W2034773963 hasConcept C121608353 @default.
• W2034773963 hasConcept C126322002 @default.
• W2034773963 hasConcept C141071460 @default.
• W2034773963 hasConcept C2775930923 @default.
• W2034773963 hasConcept C2776694085 @default.
• W2034773963 hasConcept C2776755627 @default.
• W2034773963 hasConcept C2776802502 @default.
• W2034773963 hasConcept C2777292972 @default.
• W2034773963 hasConcept C2778198053 @default.
• W2034773963 hasConcept C2781303535 @default.
• W2034773963 hasConcept C2781413609 @default.
• W2034773963 hasConcept C530470458 @default.
• W2034773963 hasConcept C71924100 @default.
• W2034773963 hasConcept C78085059 @default.
• W2034773963 hasConceptScore W2034773963C121608353 @default.
• W2034773963 hasConceptScore W2034773963C126322002 @default.
• W2034773963 hasConceptScore W2034773963C141071460 @default.
• W2034773963 hasConceptScore W2034773963C2775930923 @default.
• W2034773963 hasConceptScore W2034773963C2776694085 @default.
• W2034773963 hasConceptScore W2034773963C2776755627 @default.
• W2034773963 hasConceptScore W2034773963C2776802502 @default.
• W2034773963 hasConceptScore W2034773963C2777292972 @default.
• W2034773963 hasConceptScore W2034773963C2778198053 @default.
• W2034773963 hasConceptScore W2034773963C2781303535 @default.
• W2034773963 hasConceptScore W2034773963C2781413609 @default.
• W2034773963 hasConceptScore W2034773963C530470458 @default.
• W2034773963 hasConceptScore W2034773963C71924100 @default.
• W2034773963 hasConceptScore W2034773963C78085059 @default.
• W2034773963 hasIssue "1" @default.
• W2034773963 hasLocation W20347739631 @default.
• W2034773963 hasLocation W20347739632 @default.
• W2034773963 hasOpenAccess W2034773963 @default.
• W2034773963 hasPrimaryLocation W20347739631 @default.
• W2034773963 hasRelatedWork W187011325 @default.
• W2034773963 hasRelatedWork W1986547826 @default.
• W2034773963 hasRelatedWork W2031329688 @default.
• W2034773963 hasRelatedWork W2035712195 @default.
• W2034773963 hasRelatedWork W2091205535 @default.
• W2034773963 hasRelatedWork W2137373373 @default.
• W2034773963 hasRelatedWork W2156641782 @default.

• next